MLF数字营销平台

Home >Chemical & New materials >Chemicals >Pharmaceuticals

盐酸左氧氟沙星胶囊

Price
$ 600.00
Unit
Piece
Product number
201711221627419277
Place of Origin
中国 - 山东 - 淄博
  • Product introduction
  • EINECS No.:00
    Place Of Origin:00
    CAS No:0
    Application:0
    Appearance:0
    Purity:0
    Packing Specification:0
     药品名称:盐酸左氧氟沙星胶囊
      原料药、制剂剂型:胶囊剂
      规格:0.1g
      适应症:本品适用于敏感细菌所引起的下列轻、中度感染;

      用法用量:成人每日0.2~0.3g,分2~3次口服。病情较重者,每日最大剂量可增至0.6g,分3次口服。另外,可根据感染的种类及症状适当增减。
  • Company Name
    Shandong boshan ship pharmaceutical co., LTD.
    Place of Origin
    中国 - 山东 - 淄博

     Shandong boshan ship pharmaceutical co., LTD. Is the original on the pharmaceutical factory in 1994, restructured into limited liability company, its predecessor on the pharmaceutical factory was founded in 1970.Company existing staff more than 200 people, production, quality, management of medical engineering technicians 59 people.At present, the company has acquired by China kyushu tong medicine group, and has set up a formal investment and launched the GMP hardware, software and the rectification of the construction of the new factory building, facilities.Company's existing small capacity injection, tablet, capsule, aerosol, cream preparation, liniment, patch and API 66 varieties of eight dosage form meter 85 specification (document), original value of fixed assets of 49 million yuan, is a comprehensive pharmaceutical enterprise.Company for many years been rebuilt on the government awarded "civilized credit enterprise", is the shandong province science and technology department identified "high-tech enterprises, in 2012 was named boshan area" excellent enterprise ", growing double card compound clotrimazole cream in shandong province was named the iconic products.

    In boshan ship economic development zone, the construction of the new company is now, is in accordance with the 2010 version of the GMP to design new buildings and facilities, the company in line with high standard, high starting point, high demand to build a modern and large-scale medicine production base, is expected in 2015 August according to the new GMP certification and put into production.


Send your message to us: